Unknown

Dataset Information

0

Acellular Human Placenta Small-Diameter Vessels as a Favorable Source of Super-Microsurgical Vascular Replacements: A Proof of Concept.


ABSTRACT: In this study, we aimed to evaluate the human placenta as a source of blood vessels that can be harvested for vascular graft fabrication in the submillimeter range. Our approach included graft modification to prevent thrombotic events. Submillimeter arterial grafts harvested from the human placenta were decellularized and chemically crosslinked to heparin. Graft performance was evaluated using a microsurgical arteriovenous loop (AVL) model in Lewis rats. Specimens were evaluated through hematoxylin-eosin and CD31 staining of histological sections to analyze host cell immigration and vascular remodeling. Graft patency was determined 3 weeks after implantation using a vascular patency test, histology, and micro-computed tomography. A total of 14 human placenta submillimeter vessel grafts were successfully decellularized and implanted into AVLs in rats. An appropriate inner diameter to graft length ratio of 0.81 ± 0.16 mm to 7.72 ± 3.20 mm was achieved in all animals. Grafts were left in situ for a mean of 24 ± 4 days. Decellularized human placental grafts had an overall patency rate of 71% and elicited no apparent immunological responses. Histological staining revealed host cell immigration into the graft and re-endothelialization of the vessel luminal surface. This study demonstrates that decellularized vascular grafts from the human placenta have the potential to serve as super-microsurgical vascular replacements.

SUBMITTER: Falkner F 

PROVIDER: S-EPMC10045636 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Acellular Human Placenta Small-Diameter Vessels as a Favorable Source of Super-Microsurgical Vascular Replacements: A Proof of Concept.

Falkner Florian F   Mayer Simon Andreas SA   Thomas Benjamin B   Zimmermann Sarah Onon SO   Walter Sonja S   Heimel Patrick P   Thiele Wilko W   Sleeman Jonathan Paul JP   Bigdeli Amir Khosrow AK   Kiss Herbert H   Podesser Bruno Karl BK   Kneser Ulrich U   Bergmeister Helga H   Schneider Karl Heinrich KH  

Bioengineering (Basel, Switzerland) 20230307 3


In this study, we aimed to evaluate the human placenta as a source of blood vessels that can be harvested for vascular graft fabrication in the submillimeter range. Our approach included graft modification to prevent thrombotic events. Submillimeter arterial grafts harvested from the human placenta were decellularized and chemically crosslinked to heparin. Graft performance was evaluated using a microsurgical arteriovenous loop (AVL) model in Lewis rats. Specimens were evaluated through hematoxy  ...[more]

Similar Datasets

| S-EPMC6286260 | biostudies-literature
| S-EPMC7557107 | biostudies-literature
| S-EPMC7325062 | biostudies-literature
| S-EPMC8060745 | biostudies-literature
| S-EPMC7655903 | biostudies-literature
| PRJEB4408 | ENA
2017-05-24 | GSE89972 | GEO
| S-EPMC3403795 | biostudies-literature
| S-EPMC11539499 | biostudies-literature
2024-05-02 | GSE245870 | GEO